Original Research

Published on 07 Feb 2024

A novel serum m7G-harboring microRNA signature for cancer detection

in Cancer Genetics and Oncogenomics

Yaxin Chen
Yufang Xie
Liyun Bi
Hang Ci
Weimin Li
Dan Liu

Frontiers in Genetics

doi 10.3389/fgene.2024.1270302

1,546 views
1 citation

Original Research

Published on 26 Jan 2024

Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection

in Cancer Genetics and Oncogenomics

Bang Liu
Ling-Ling Lu
Li Yu
Xuan Mei
Jia Liu
Jiao-Long Zheng
Xiao-Ling Zhou
Hai-Yan Lin
Xiu-Ling Zhu
Dong-Liang Li

Frontiers in Genetics

doi 10.3389/fgene.2023.1326737

2,977 views

Correction

Published on 26 Jan 2024

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

in Cancer Genetics and Oncogenomics

Sheng Liu
Wenting Tang
Jing Cao
Mei Shang
Sun Hengchang
Jiao Gong
Bo Hu

Frontiers in Genetics

doi 10.3389/fgene.2024.1357409

938 views

Review

Published on 26 Jan 2024

Associations between MTHFR gene polymorphisms (C677T and A1298C) and genetic susceptibility to prostate cancer: a systematic review and meta-analysis

in Cancer Genetics and Oncogenomics

Jianan You
Yuhua Huang
Xinyu Shen
Yunyi Chen
Xiang Ding

Frontiers in Genetics

doi 10.3389/fgene.2024.1343687

1,775 views
2 citations

General Commentary

Published on 25 Jan 2024

Commentary: Identification of optimal reference genes for gene expression normalization in human osteosarcoma cell lines under proliferative conditions

in Cancer Genetics and Oncogenomics

Paulo R. C. de Sousa
Andreon S. M. da Silva
Carlos G. G. de Ponte
Lucas L. Nogueira
Cristiane C. Frota
Paulo R. Z. Antas

Frontiers in Genetics

doi 10.3389/fgene.2024.1342447

817 views

Original Research

Published on 23 Jan 2024

Integrated transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, Hippo/Wnt, TGF-β and MAPK signaling pathways in ovarian cancer cells response to cannabis and PARP1 inhibitor treatment

in Cancer Genetics and Oncogenomics

Nurit Shalev
Michelle Kendall
Navin Kumar
Sudeep Tiwari
Seegehalli M. Anil
Hagit Hauschner
Savvemala G. Swamy
Adi Doron-Faingenboim
Eduard Belausov
Bruce E. Kendall

Frontiers in Genetics

doi 10.3389/fgene.2024.1333964

2,088 views

Original Research

Published on 22 Jan 2024

Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study

in Cancer Genetics and Oncogenomics

Shanshan Qin
Jing Wang
Haiqing Yuan
Jingzhen He
Shoujing Luan
Yan Deng

Frontiers in Genetics

doi 10.3389/fgene.2023.1260352

3,577 views
2 citations

Editorial

Published on 22 Jan 2024

Editorial: Recent advances in the molecular genetics and precision medicine of lung carcinoma

in Cancer Genetics and Oncogenomics

Mehdi Pirooznia
Xiaogang Wu
Jonathan N. Bella
Fan Zhang
Dragana Jovanovic

Frontiers in Genetics

doi 10.3389/fgene.2024.1369247

1,382 views
1 citation

Original Research

Published on 18 Jan 2024

Historical evolution of cancer genomics research in Latin America: a comprehensive visual and bibliometric analysis until 2023

in Cancer Genetics and Oncogenomics

Ivan David Lozada-Martinez
Luz Miryam Lozada-Martinez
Andrés Cabarcas-Martinez
Franklin Kevin Ruiz-Gutierrez
Jose Gabriel Aristizabal Vanegas
Katherine Julieth Amorocho Lozada
Lina María López-Álvarez
Ornella Fiorillo Moreno
Elkin Navarro Quiroz

Frontiers in Genetics

doi 10.3389/fgene.2024.1327243

1,943 views
6 citations

Original Research

Published on 15 Jan 2024

Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy

in Cancer Genetics and Oncogenomics

Aleksandra Stanojevic
Jelena Spasic
Mladen Marinkovic
Suzana Stojanovic-Rundic
Radmila Jankovic
Ana Djuric
Jerome Zoidakis
Remond J. A. Fijneman
Sergi Castellvi-Bel
Milena Cavic

Frontiers in Genetics

doi 10.3389/fgene.2023.1299599

2,280 views
5 citations

Mini Review

Published on 12 Jan 2024

Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?

in Cancer Genetics and Oncogenomics

Maria Tsagiopoulou
Ivo G. Gut

Frontiers in Genetics

doi 10.3389/fgene.2023.1304661

2,509 views
4 citations

Original Research

Published on 04 Jan 2024

Dissecting cellular heterogeneity and intercellular communication in cholangiocarcinoma: implications for individualized therapeutic strategies

in Cancer Genetics and Oncogenomics

Zun-Qiang Zhou
Yi Zhang
Zi-Yang Xu
Xiao-Li Tang
Xiao-Hua Chen
Jiao Guan
Zheng-Yun Zhang

Frontiers in Genetics

doi 10.3389/fgene.2023.1241834

1,783 views

Original Research

Published on 21 Dec 2023

Two-sample Mendelian randomization study reveals no causal relationship between inflammatory bowel disease and urological cancers

in Cancer Genetics and Oncogenomics

Haoyang Zhang
Can Hu
Zhiyu Zhang
Peng Li
Gang Shen
Jiale Sun

Frontiers in Genetics

doi 10.3389/fgene.2023.1275247

2,710 views

Original Research

Published on 18 Dec 2023

Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide

in Cancer Genetics and Oncogenomics

Tonia Carter
Robert K. Valenzuela
Srinivasulu Yerukala Sathipati
Rafael Medina-Flores

Frontiers in Genetics

doi 10.3389/fgene.2023.1320789

2,731 views
1 citation

Review

Published on 14 Dec 2023

Unveiling immune checkpoint regulation: exploring the power of in vivo CRISPR screenings in cancer immunotherapy

in Cancer Genetics and Oncogenomics

Yuxiang Wang
Athar Khalil
Amina Kamar
Mengyan Du
Trang Dinh
Christopher McFarland
Zhenghe Wang

Frontiers in Genetics

doi 10.3389/fgene.2023.1304425

2,365 views

Editorial

Published on 14 Dec 2023

Editorial: Current trends and future perspectives about liquid biopsy

in Cancer Genetics and Oncogenomics

Elisa Frullanti
María José Serrano

Frontiers in Genetics

doi 10.3389/fgene.2023.1345876

1,408 views

Navigation group

Articles

A novel serum m7G-harboring microRNA signature for cancer detection

Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Associations between MTHFR gene polymorphisms (C677T and A1298C) and genetic susceptibility to prostate cancer: a systematic review and meta-analysis

Commentary: Identification of optimal reference genes for gene expression normalization in human osteosarcoma cell lines under proliferative conditions

Integrated transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, Hippo/Wnt, TGF-β and MAPK signaling pathways in ovarian cancer cells response to cannabis and PARP1 inhibitor treatment

Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study

Editorial: Recent advances in the molecular genetics and precision medicine of lung carcinoma

Historical evolution of cancer genomics research in Latin America: a comprehensive visual and bibliometric analysis until 2023

Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy

Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?

Dissecting cellular heterogeneity and intercellular communication in cholangiocarcinoma: implications for individualized therapeutic strategies

Two-sample Mendelian randomization study reveals no causal relationship between inflammatory bowel disease and urological cancers

Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide

Unveiling immune checkpoint regulation: exploring the power of in vivo CRISPR screenings in cancer immunotherapy

Editorial: Current trends and future perspectives about liquid biopsy